Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Carcinoma and GALNT14[original query] |
---|
GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC. Pharmacogenomics 2011 Jul 12 (7): 1061-73. Liang Kung-Hao, Lin Chen-Chun, Yeh Chau-Ti |
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. International journal of cancer. Journal international du cancer 2014 Mar 134 (5): 1214-24. Yeh Chau-Ting, Liang Kung-Hao, Lin Chen-Chun, Chang Ming-Ling, Hsu Cheng-Lung, Hung Chien- |
GALNT14 genotype, a-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma. Molecular and clinical oncology 2014 Jul 2 (4): 630-640. Lin Wey-Ran, Hsu Chao-Wei, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Huang Ya-Hui, Yeh Chau-Ti |
Genotyping the GALNT14 gene by joint analysis of two linked single nucleotide polymorphisms using liver tissues for clinical and geographical comparisons. Oncology letters 2014 Nov 8 (5): 2215-2220. Liang Kung-Hao, Yang Pei-Ching, Yeh Chau-Ti |
GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy. Medicine 2016 Apr 95 (17): e3487. Lin Wey-Ran, Chiang Jy-Ming, Liang Kung-Hao, Lim Siew-Na, Lai Ming-Wei, Tsou Yung-Kuan, Hsieh Tzu-Yun, Hsu Chih-Kai, Yeh Chau-Ti |
GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Pharmacogenomics 2016 Feb . Liang Kung-Hao, Lin Chih-Lang, Chen Sung-Fang, Chiu Chih-Wei, Yang Pei-Ching, Chang Ming-Ling, Lin Chen-Chun, Sung Kai-Feng, Yeh Cassandra, Hung Chien-Fu, Chien Rong-Nan, Yeh Chau-Ti |
Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma. Asia-Pacific journal of clinical oncology 2017 Jul . Lin Wey-Ran, Hsu Chao-Wei, Yeh Christopher Sung-Huan, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Lin Chen-Chun, Chu Yu-De, Yeh Chau-Ti |
GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma. Oncology letters 2017 Jun 13 (6): 4215-4223. Liang Kung-Hao, Yeh Ta-Sen, Wu Ren-Chin, Yeh Chun-Nan, Yeh Chau-Ti |
GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma. Oncotarget 2017 Mar . Tsou Yung-Kuan, Liang Kung-Hao, Lin Wey-Ran, Chang Hsien-Kun, Tseng Chen-Kan, Yeh Chau-Ti |
Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype. Journal of Cancer 2018 10 9 (19): 3540-3547. Chen Tsung-Hsing, Lin Wey-Ran, Lee Chieh, Chiu Cheng-Tang, Hsu Jun-Te, Yeh Ta-Sen, Lin Kwang-Huei, Le Puo-Hsien, Yeh Chau-Ti |
A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy. The pharmacogenomics journal 2019 Oct . Lin Chen-Chun, Hsu Chao-Wei, Chen Yi-Cheng, Chang Ming-Ling, Liang Kung-Hao, Lai Ming-Wei, Lin Chih-Lang, Chien Rong-Nan, Lin Kwang-Huei, Yeh Chau-Ti |
GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers. International journal of molecular sciences 2020 2 21 (4): . Lin Wey-Ran, Yeh Chau-Ti |
Association of rs9679162 Genetic Polymorphism and Aberrant Expression of Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) in Head and Neck Cancer. Cancers 2022 Aug 14 (17): . Lin Nan-Chin, Shih Yin-Hwa, Chiu Kuo-Chou, Li Po-Jung, Yang Hui-Wu, Lan Wan-Chen, Hsia Shih-Min, Wang Tong-Hong, Shieh Tzong-Mi |
WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma. Frontiers in oncology 2022 12 12 996820. Chu Yu-De, Liu Hui-Fen, Chen Yi-Chen, Chou Chun-Hung, Yeh Chau-Ti |
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology international 2022 1 16 (1): 148-158. Chen Wei-Ting, Lin Shi-Ming, Lee Wei-Chen, Wu Ting-Jung, Lin Chen-Chun, Shen Chien-Heng, Chang Ming-Ling, Lin Chih-Lang, Yeh Chau-Ti |
Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib. Cancer biomarkers : section A of Disease markers 2023 3 . Lin Chih-Lang, Chien Rong-Nan, Chen Li-Wei, Chu Yu-De, Yeh Chau-Ti |
Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma. Cancer medicine 2023 12 . Shicheng Zhan, Moqin Qiu, Xueyan Wei, Junjie Wei, Liming Qin, Binbin Jiang, Qiuping Wen, Peiqin Chen, Qiuling Lin, Xiaoxia Wei, Zihan Zhou, Yanji Jiang, Xiumei Liang, Runwei Li, Yingchun Liu, Hongping |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: